Cargando…
Hydrocortisone/tocilizumab: Cytomegalovirus haemorrhagic enterocolitis and off-label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933401/ http://dx.doi.org/10.1007/s40278-021-92079-z |
Ejemplares similares
-
Hydroxychloroquine/tocilizumab: Cytomegalovirus enterocolitis and hypovolaemic-shock following off-label use: case report
Publicado: (2020) -
Hydrocortisone/methylprednisolone/tocilizumab: Various toxicities following off-label treatment: case report
Publicado: (2021) -
Tocilizumab: Cytomegalovirus colitis following off label use: case report
Publicado: (2021) -
Hydrocortisone/tocilizumab: Candida albicans infection and acalculous cholecystitis secondary to off-label use: case report
Publicado: (2021) -
Methylprednisolone/tocilizumab: Cytomegalovirus gastritis following off label use: case report
Publicado: (2022)